KR20030085788A - Pyridine derivatives, process for the preparation thereof, and use as an intermediate of herbicides - Google Patents
Pyridine derivatives, process for the preparation thereof, and use as an intermediate of herbicides Download PDFInfo
- Publication number
- KR20030085788A KR20030085788A KR1020020024057A KR20020024057A KR20030085788A KR 20030085788 A KR20030085788 A KR 20030085788A KR 1020020024057 A KR1020020024057 A KR 1020020024057A KR 20020024057 A KR20020024057 A KR 20020024057A KR 20030085788 A KR20030085788 A KR 20030085788A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- alkyl
- solvent
- reacting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
본 발명은 신규한 하기 화학식 (1)의 피리딘 유도체, 그의 제조방법, 및 우수한 제초활성을 나타내는 하기 화학식 (2)의 플루오로알킬피리딘-설포닐우레아 유도체의 중간체로서의 용도에 관한 것이다.The present invention relates to a novel pyridine derivative of formula (1), a process for preparing the same, and a use as an intermediate of a fluoroalkylpyridine-sulfonylurea derivative of formula (2) exhibiting excellent herbicidal activity.
[화학식 1][Formula 1]
[화학식 2][Formula 2]
상기식에서,In the above formula,
R1은 수소, 시아노, C1-C4-알킬, C3-C6-사이클로알킬, C1-C4-알킬카보닐, C1-C4-알콕시메틸, 또는 -C(=S)OEt를 나타내거나, 할로겐, C1-C4-알킬 및 C1-C4-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타내거나,R 1 is hydrogen, cyano, C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkylcarbonyl, C 1 -C 4 -alkoxymethyl, or -C (= S Or benzyl unsubstituted or substituted 1 to 5 by a substituent selected from halogen, C 1 -C 4 -alkyl and C 1 -C 4 -alkoxy,
R1은 SQ를 나타내며, 여기에서 Q는 하기 피리딘 라디칼을 나타내고:R 1 represents SQ, where Q represents the following pyridine radical:
Q: Q:
R2는 수소 또는 C1-C4-알킬을 나타내며,R 2 represents hydrogen or C 1 -C 4 -alkyl,
Y는 할로겐 원자를 나타내고,Y represents a halogen atom,
R3는 수소 또는 C1-C4-알킬카보닐을 나타낸다.R 3 represents hydrogen or C 1 -C 4 -alkylcarbonyl.
특히, R1이 SQ를 나타내는 경우 화학식 1의 화합물은 하기 화학식 (1a)의 대칭구조의 디설파이드 화합물을 이루게 된다.In particular, when R 1 represents SQ, the compound of Formula 1 forms a disulfide compound having a symmetric structure of the following Formula (1a).
본 발명에 따른 화학식 (1)의 화합물은, 선행기술(WO 92/14728, WO 96/12708, WO 97/31913호 참조)에 우수한 제초 활성을 지닌 것으로 공지된 하기 화학식 (2)의 플루오로알킬피리딘-설포닐우레아 유도체를 제조하기 위한 중간체로서 유용하게 사용될 수 있다.Compounds of formula (1) according to the invention are fluoroalkyls of formula (2) which are known to have excellent herbicidal activity in the prior art (see WO 92/14728, WO 96/12708, WO 97/31913). It can be usefully used as an intermediate for preparing pyridine-sulfonylurea derivatives.
[화학식 2][Formula 2]
상기식에서, R2및 R3는 앞에서 정의한 바와 같다.Wherein R 2 and R 3 are as defined above.
WO 92/14728, WO 96/12708 및 WO 97/31913호에 공지된 바에 따르면, 화학식 (2)의 플루오로알킬피리딘-설포닐우레아 유도체는 핵심 중간체로서 하기 화학식 (5)의 피리딜케톤 화합물을 경유하여 합성된다.As known from WO 92/14728, WO 96/12708 and WO 97/31913, the fluoroalkylpyridine-sulfonylurea derivatives of formula (2) can be used as It is synthesized via.
상기식에서 R2는 앞에서 정의한 바와 같다.Wherein R 2 is as defined above.
하지만 핵심 중간체인 화학식 (5)의 피리딜케톤 화합물을 합성하는 과정에 몇가지 문제점이 발견되었다. 즉, 하기 반응식 (1)에 나타낸 바와 같이, 피리딘환의 2번 위치에 탄소-탄소 결합을 도입하는 과정에서n-BuLi을 사용하기 때문에 -70℃ 이하의 극한조건 및 극도의 무수조건을 필요로 하고 있는 것이다:However, some problems have been found in synthesizing the pyridyl ketone compound of formula (5) which is a key intermediate. That is, as shown in the following reaction formula (1), since n- BuLi is used in the process of introducing a carbon-carbon bond to the position 2 of the pyridine ring, it is required to have an extreme condition of -70 ° C. or less and an extreme anhydrous condition. Is:
더구나, 피리딘의 3번 위치에 설폰아미드를 미리 도입했기 때문에 아미드의 탈수소 반응에 의한 부반응이 발생할 수 있어 주의를 요하게 되므로 대량 생산을 위해서는 좀더 용이하게 접근할 수 있는 유리한 방법을 필요로 하고 있다.Moreover, since sulfonamide has been introduced at position 3 of pyridine in advance, side reactions may occur due to dehydrogenation of amides, which requires attention.
이에 본 발명자들은 우수한 제초제 화합물의 핵심 중간체인 화학식 (5)의 피리딜케톤 화합물을 간편하게 제조할 수 있는 방법을 고안하고자 집중적인 연구를 수행하였으며, 그 과정에서 상기 화학식 (1)의 신규 화합물을 개발하고 이 화합물이 화학식 (5)의 화합물을 제조하는데 매우 유용하게 사용될 수 있음을 발견한 결과 본 발명을 완성하게 되었다.Therefore, the present inventors conducted intensive research to devise a method for easily preparing a pyridyl ketone compound of formula (5), which is a key intermediate of an excellent herbicide compound, and in the process, developed a new compound of formula (1). The present invention has been completed as a result of discovering that the compound can be very useful for preparing the compound of formula (5).
따라서, 본 발명은 화학식 (1)의 신규 피리딘 유도체를 제공함을 목적으로 한다.It is therefore an object of the present invention to provide novel pyridine derivatives of formula (1).
본 발명의 목적은 또한, 화학식 (1)의 화합물을 제조하는 방법을 제공한다.It is also an object of the present invention to provide a process for preparing the compound of formula (1).
본 발명의 목적은 또한, 화학식 (1)의 화합물을 사용하여 화학식 (5)의 화합물을 제조하는 방법을 제공한다.It is also an object of the present invention to provide a process for preparing a compound of formula (5) using a compound of formula (1).
본 발명은 하기 화학식 (1)의 신규한 피리딘 유도체에 관한 것이다:The present invention relates to novel pyridine derivatives of formula (1)
[화학식 1][Formula 1]
상기식에서,In the above formula,
R1은 수소, 시아노, C1-C4-알킬, C3-C6-사이클로알킬, C1-C4-알킬카보닐, C1-C4-알콕시메틸, 또는 -C(=S)OEt를 나타내거나, 할로겐, C1-C4-알킬 및 C1-C4-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타내거나,R 1 is hydrogen, cyano, C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkylcarbonyl, C 1 -C 4 -alkoxymethyl, or -C (= S Or benzyl unsubstituted or substituted 1 to 5 by a substituent selected from halogen, C 1 -C 4 -alkyl and C 1 -C 4 -alkoxy,
R1은 SQ를 나타내며, 여기에서 Q는 하기 피리딘 라디칼을 나타내고:R 1 represents SQ, where Q represents the following pyridine radical:
Q: Q:
R2는 수소 또는 C1-C4-알킬을 나타내며,R 2 represents hydrogen or C 1 -C 4 -alkyl,
Y는 할로겐 원자를 나타낸다.Y represents a halogen atom.
특히, R1이 SQ를 나타내는 경우 화학식 1의 화합물은 하기 화학식 (1a)의 대칭구조의 디설파이드 화합물을 이루게 된다.In particular, when R 1 represents SQ, the compound of Formula 1 forms a disulfide compound having a symmetric structure of the following Formula (1a).
[화학식 1a][Formula 1a]
본 명세서에서 언급된 치환체들은 다음의 의미를 지닌다.Substituents mentioned herein have the following meanings.
할로겐은 불소, 염소, 브롬, 요오드를 의미하며 바람직하게는 불소, 염소, 브롬을 의미한다.Halogen means fluorine, chlorine, bromine, iodine and preferably fluorine, chlorine, bromine.
알킬은 메틸, 에틸,n-프로필, 이소프로필,n-부틸, 또는 여러가지의 부틸 이성체와 같은 직쇄 또는 측쇄 포화 탄화수소를 의미하며 바람직하게는 메틸, 에틸,n-프로필, 이소프로필, 또는t-부틸을 의미한다.Alkyl means a straight or branched chain saturated hydrocarbon such as methyl, ethyl, n -propyl, isopropyl, n -butyl, or various butyl isomers, preferably methyl, ethyl, n -propyl, isopropyl, or t- butyl Means.
알콕시는 메톡시, 에톡시,n-프로폭시, 이소프로폭시,n-부톡시, 또는 여러가지의 부틸 이성체와 같은 직쇄 또는 측쇄 포화 탄화수소옥시를 의미하며 바람직하게는 메톡시 또는 에톡시를 의미한다.Alkoxy are methoxy, ethoxy, n - it represents a butoxy, or straight or means a branched saturated hydrocarbon oxy, and preferably methoxy or ethoxy, such as the various butyl isomers-propoxy, isopropoxy, n.
사이클로알킬은 사이클로프로필, 사이클로부틸, 사이클로펜틸, 또는 사이클로헥실을 의미하며, 바람직하게는 사이클로프로필 또는 사이클로헥실을 의미한다.Cycloalkyl means cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl, preferably cyclopropyl or cyclohexyl.
알킬카보닐은 아세틸, 프로피오닐,n-부티로일, 이소부티로일,s-부티로일, 또는t-부티로일을 의미하며 바람직하게는 아세틸을 의미한다.Alkylcarbonyl means acetyl, propionyl, n- butyroyl, isobutyroyl, s- butyroyl, or t- butyroyl and preferably means acetyl.
알콕시메틸은 메톡시메틸, 에톡시메틸,n-프로폭시메틸, 이소프로폭시메틸,n-부톡시메틸, 이소부톡시메틸,s-부톡시메틸, 또는t-부톡시메틸을 의미하며 바람직하게는 메톡시메틸을 의미한다.Alkoxymethyl means methoxymethyl, ethoxymethyl, n -propoxymethyl, isopropoxymethyl, n -butoxymethyl, isobutoxymethyl, s -butoxymethyl, or t -butoxymethyl, preferably Means methoxymethyl.
상기 본 발명에 따른 화학식 (1)의 화합물중에서도 바람직한 화합물은 R1이 C1-C4-알킬 및 C1-C4-알콕시로부터 선택된 치환체에 의해 1 내지 5 치환되거나 비치환된 벤질을 나타내거나, C1-C4-알킬, C1-C4-알콕시메틸, -C(=S)OEt, 또는 SQ를 나타내며, 여기에서 Q는 앞에서 정의한 바와 같고, R2가 수소, 메틸 또는 에틸을 나타내며, Y가 불소, 염소 또는 브로모 원자를 나타내는 화합물이다.Preferred compounds among the compounds of formula (1) according to the present invention R 1 is C 1 -C 4 - alkyl and C 1 -C 4 - substituted by 1 to 5 substituents selected from alkoxy, or represent or an unsubstituted benzyl , C 1 -C 4 -alkyl, C 1 -C 4 -alkoxymethyl, -C (= S) OEt, or SQ, wherein Q is as defined above and R 2 represents hydrogen, methyl or ethyl , Y represents a fluorine, chlorine or bromo atom.
더욱 바람직한 화합물은 R1이 4-메톡시벤질, 벤질, 이소프로필, t-부틸, 메톡시메틸, -C(=S)OEt, 또는 SQ를 나타내며, 여기에서 Q는 앞에서 정의한 바와 같고, R2가 수소, 메틸 또는 에틸을 나타내며, Y가 불소, 염소 또는 브로모 원자를 나타내는 화합물이다.More preferred compounds are those in which R 1 represents 4-methoxybenzyl, benzyl, isopropyl, t-butyl, methoxymethyl, -C (= S) OEt, or SQ, wherein Q is as defined above and R 2 Is hydrogen, methyl or ethyl, and Y is a fluorine, chlorine or bromo atom.
본 발명에 따른 화학식 (1)의 화합물은 하기 화학식 (6)의 화합물을 용매중에서 하기 화학식 (7)의 구리(II)염과 반응시켜 하기 화학식 (1c)의 화합물을 제조하거나, 수득된 화학식 (1c)의 화합물을 용매중에서 임의로 상전이촉매의 존재하에 하기 화학식 (8)의 화합물과 반응시켜 하기 화학식 (1b)의 화합물을 제조함을 특징으로 하여 제조할 수 있다. 따라서, 본 발명은 이러한 화학식 (1)의 화합물의 제조방법을 제공하는 것을 또다른 목적으로 한다.The compound of formula (1) according to the present invention is prepared by reacting a compound of formula (6) with a copper (II) salt of formula (7) in a solvent to prepare a compound of formula (1c), The compound of formula (c) can be prepared by reacting the compound of formula (8) with a compound of formula (8), optionally in the presence of a phase transfer catalyst in a solvent. Accordingly, another object of the present invention is to provide a method for preparing such a compound of formula (1).
상기 반응들을 각기 반응식으로 도시하고 구체적인 반응조건에 대해 자세히 설명하면 다음과 같다.The reactions are shown in the respective reaction formulas and detailed reaction conditions are as follows.
상기식에서In the above formula
R1및 R2는 앞에서 정의한 바와 같고,R 1 and R 2 are as defined above,
Y'는 염소 또는 브로모 원자를 나타낸다.Y 'represents a chlorine or bromo atom.
반응식 2의 방법에서 화학식 (6)의 케톤 화합물을 2 내지 3당량의 상응하는 구리(II)염, 즉, Y'가 염소인 경우에는 CuCl2와 반응시키거나, Y'가 브로모인 경우에는 CuBr2와 각각 반응시켜 목적하는 화학식 (1c)의 화합물을 얻을 수 있다.In the process of Scheme 2, the ketone compound of formula (6) is reacted with 2 to 3 equivalents of the corresponding copper (II) salt, ie CuCl 2 if Y 'is chlorine, or CuBr if Y' is bromo Reaction with 2 may be carried out to obtain a compound of the formula (1c).
이 반응에서 용매는 스스로 반응에 참여하지 않는 통상의 용매를 사용할 수 있으며, 바람직하게는 클로로포름, 디클로로메탄, 디클로로에탄 등의 염화탄화수소류, 톨루엔, 벤젠, 크실렌 등의 방향족 탄화수소류, 메틸 아세테이트, 에틸 아세테이트, 이소프로필 아세테이트 등의 아세테이트류, 메탄올, 에탄올, 이소프로판올 등의 알콜류, 디메틸에테르, 디에틸에테르, 메틸 t-부틸에테르, 디메톡시에탄, 테트라하이드로푸란, 디옥산 등의 에테르류를 단독으로 또는 혼합하여 사용한다.In this reaction, a solvent may be used a conventional solvent that does not participate in the reaction by itself, preferably hydrocarbons such as chloroform, dichloromethane, dichloroethane, aromatic hydrocarbons such as toluene, benzene, xylene, methyl acetate, ethyl Acetates such as acetate and isopropyl acetate, alcohols such as methanol, ethanol and isopropanol, ethers such as dimethyl ether, diethyl ether, methyl t-butyl ether, dimethoxyethane, tetrahydrofuran and dioxane alone or Use by mixing.
반응온도는 -20℃ 내지 150℃의 범위에서 수행가능하며, 10℃ 내지 80℃ 범위가 바람직하다.The reaction temperature can be carried out in the range of -20 ° C to 150 ° C, preferably 10 ° C to 80 ° C.
출발물질로 사용된 화학식 (6)의 피리딜 케톤 화합물은 문헌(참조: Kevin A. Memoli,Tetrahedron Letters37, 3617(1996); DE 4304007 A1; 또는 Blank, B. et al., J. Med. Chem. 1974, 17, pp1065-1071)에 공지되어 있거나 여기에 개시된 것과 동일한 방법으로 쉽게 제조할 수 있다.Pyridyl ketone compounds of formula (6) used as starting materials are described in Kevin A. Memoli, Tetrahedron Letters 37, 3617 (1996); DE 4304007 A1; or Blank, B. et al., J. Med. Chem. 1974, 17, pp 1065-1071) or readily prepared by the same method as disclosed herein.
한편, 본 발명에 따른 화학식 (1)의 화합물 중에서 Y=F인 화합물, 즉, 화학식 (1b)의 화합물은 하기 반응식 3에 도시한 바와 같이 화학식 (1c)의 화합물을 화학식 (8)의 상응하는 친핵체와 치환 반응시켜 얻을 수 있다.On the other hand, among the compounds of the formula (1) according to the present invention Y = F, that is, a compound of the formula (1b) is a compound of the formula (1c) corresponding to the formula (8) It can obtain by substitution reaction with a nucleophile.
상기식에서In the above formula
R1및 R2는 앞에서 정의한 바와 같고,R 1 and R 2 are as defined above,
Y'는 염소 또는 브로모 원자를 나타내며,Y 'represents a chlorine or bromo atom,
M은 알칼리 금속을 나타낸다.M represents an alkali metal.
화학식 (8)의 친핵체로는 알칼리 금속의 불화화합물이 사용되며, 바람직하게는 불화나트륨, 불화칼륨 또는 불화리튬 등을 사용할 수 있다. 화학식 (8)의 친핵체는 화학식 (1c)의 화합물에 대해 1 내지 3당량배량으로 반응시키는 것이 바람직하다.As the nucleophile of the formula (8), a fluoride compound of an alkali metal is used, and preferably sodium fluoride, potassium fluoride or lithium fluoride can be used. The nucleophile of the formula (8) is preferably reacted with 1 to 3 equivalents to the compound of the formula (1c).
용매로는 극성용매를 사용하는 것이 좋으며, 바람직하게는 포름아미드, 디메틸포름아미드, 디메틸아세트아미드 등의 아미드류, 에틸렌글리콜, 폴리에틸렌글리콜 등의 글리콜류, 아세토니트릴, 프로피오니트릴 등의 니트릴류를 사용한다.It is preferable to use a polar solvent as the solvent. Preferably, amides such as formamide, dimethylformamide and dimethylacetamide, glycols such as ethylene glycol and polyethylene glycol, nitriles such as acetonitrile and propionitrile use.
상기 반응은 크라운에테르나 4차알킬암모늄염을 상전이촉매로 사용함으로써 촉진될 수 있다. 4차알킬암모늄염으로는 트리에틸벤질암모늄클로라이드, 테트라부틸암모늄플루오라이드, 트리옥틸메틸암모늄플루오라이드, 테트라부틸암모늄브로마이드 등이 바람직하게 사용된다.The reaction can be promoted by using crown ethers or quaternary alkylammonium salts as phase transfer catalysts. As the quaternary alkylammonium salt, triethylbenzyl ammonium chloride, tetrabutylammonium fluoride, trioctylmethylammonium fluoride, tetrabutylammonium bromide and the like are preferably used.
반응온도는 20℃ 내지 150℃의 범위에서 수행가능하며, 20℃ 내지 130℃ 범위가 바람직하다.The reaction temperature can be carried out in the range of 20 ° C to 150 ° C, preferably 20 ° C to 130 ° C.
상기 설명한 방법에 따라 제조된 본 발명에 따른 화학식 (1)의 화합물의 좀더 명확히 하기 위하여 개개 화합물로 예시하여 나타내면 하기 표 1과 같다.To clarify the compounds of the formula (1) according to the present invention prepared according to the above-described method as shown in the individual compounds as shown in Table 1 below.
공지 화합물이거나 공지 화합물로부터 쉽게 얻을 수 있는 화학식 (6)의 피리딜케톤 화합물로부터, 극도의 저온 또는 무수조건을 유지할 필요없이 훨씬 온화한 반응조건하에 제조된 본 발명에 따른 화학식 (1b)의 화합물은 화학식 (5)의 화합물을 제조하는데 매우 유용하게 사용되며, 이에 따라 제조된 화학식 (5)의 화합물은 우수한 제초활성을 지닌 화학식 (2)의 플루오로알킬피리딘-설포닐 우레아 유도체를 제조함에 있어 핵심 중간체로 사용된다.From pyridylketone compounds of formula (6), which are known compounds or readily obtainable from known compounds, the compounds of formula (1b) according to the invention prepared under much mild reaction conditions without the need to maintain extreme low temperature or anhydrous conditions are Very usefully used to prepare the compound of (5), the compound of formula (5) thus prepared is a key intermediate in the preparation of fluoroalkylpyridine-sulfonyl urea derivatives of formula (2) with excellent herbicidal activity Used as
즉, 본 발명에 따르면, 화학식 (1b)의 화합물을 물 또는 아세트산 수용액과 유기용매의 혼합액중에서 염소 기체와 반응시킨 후 이를 유기용매중에서 t-부틸아민과 반응시킴으로써 화학식 (5)의 화합물을 제조하는 방법이 제공되며, 이를 반응식으로 도시하면 하기 반응식 (4)와 같다.That is, according to the present invention, a compound of formula (5) is prepared by reacting a compound of formula (1b) with chlorine gas in a mixture of water or an acetic acid aqueous solution and an organic solvent and then reacting it with t-butylamine in an organic solvent. A method is provided, which is shown in Scheme (4).
상기식에서, R1및 R2는 앞에서 정의한 바와 같다.Wherein R 1 and R 2 are as defined above.
상기 반응을 수행함에 따라 화학식 (1b)의 화합물에 포함된 머캅토에테르기가 설폰아미드기로 전환되게 된다.As the reaction is carried out, the mercaptoether group included in the compound of formula (1b) is converted into a sulfonamide group.
먼저, 염소 기체와 반응시키는 첫 번째 단계에서 용매로는 스스로 반응에 참여하지 않는 통상의 용매를 사용할 수 있으며, 구체적으로는 물 또는 아세트산 수용액과 유기용매를 1:1 내지 1:3의 부피비로 혼합시킨 것을 사용한다. 이때, 유기용매로는 톨루엔, 벤젠, 크실렌 등의 방향족 탄화수소류, 클로로포름, 디클로로메탄, 1,2-에틸렌디클로라이드 등의 염화탄화수소류, 디메틸에테르, 디에틸에테르, 메틸 t-부틸에테르, 디메톡시에탄, 테트라하이드로푸란, 디옥산 등의 에테르류를 바람직하게 사용한다. 상기 반응은 물 대신 10 내지 30%의 묽은 아세트산을 사용함으로써 촉진될 수 있다. 반응온도는 -20℃ 내지 80℃ 범위이며 0℃ 내지 40℃ 범위가 바람직하다.First, in the first step of reacting with chlorine gas, a conventional solvent that does not participate in the reaction itself may be used. Specifically, water or acetic acid aqueous solution and an organic solvent are mixed in a volume ratio of 1: 1 to 1: 3. Use what you have. At this time, as the organic solvent, aromatic hydrocarbons such as toluene, benzene, xylene, chlorinated hydrocarbons such as chloroform, dichloromethane, 1,2-ethylenedichloride, dimethyl ether, diethyl ether, methyl t-butyl ether, dimethoxy Ethers, such as ethane, tetrahydrofuran, and dioxane, are used preferably. The reaction can be promoted by using 10-30% dilute acetic acid in place of water. The reaction temperature is in the range of -20 deg. C to 80 deg. C with a preferred range of 0 deg. C to 40 deg.
t-부틸아민과 반응시키는 두번째 단계에서 용매로는 클로로포름, 디클로로메탄, 디클로로에탄 등의 염화탄화수소류 또는 톨루엔, 벤젠, 크실렌 등의 방향족 탄화수소류를 바람직하게 사용한다. 또는, 첫 번째 단계 반응을 수행한 후 별도의 정제과정 없이 유기용매층을 그대로 사용할 수 있다. t-부틸아민은 1 내지 2 당량의 양으로 천천히 적가하여 사용한다. 반응온도는 -20℃ 내지 100℃ 범위이며, -20℃ 내지 30℃ 범위가 바람직하다.In the second step of reacting with t-butylamine, as the solvent, chlorinated hydrocarbons such as chloroform, dichloromethane and dichloroethane or aromatic hydrocarbons such as toluene, benzene and xylene are preferably used. Alternatively, the organic solvent layer may be used as it is without any further purification after the first step reaction. t-butylamine is slowly added dropwise in an amount of 1 to 2 equivalents. The reaction temperature is in the range of -20 ° C to 100 ° C, preferably in the range of -20 ° C to 30 ° C.
이하, 본 발명을 하기 제조예 및 실시예에 의거하여 보다 구체적으로 설명한다. 그러나, 이들 제조예 및 실시예는 본 발명에 대한 이해를 돕기 위한 것일 뿐, 어떤 의미로든 본 발명의 범위가 이들에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail based on the following Preparation Examples and Examples. However, these preparation examples and examples are only for the understanding of the present invention, and the scope of the present invention in any sense is not limited thereto.
제조예 1Preparation Example 1
1-(3-이소프로필설파닐피리딘-2-일)-프로판-1-온의 합성Synthesis of 1- (3-isopropylsulfanylpyridin-2-yl) -propan-1-one
2-시아노-3-이소프로필설파닐피리딘(3.56g, 20mmol)을 테트라하이드로푸란 (40㎖)에 녹이고 여기에 3M 에틸마그네슘브로마이드의 에테르 용액(8㎖)을 0℃에서 적가하였다. 출발물질이 완전히 소모되면 1시간동안 상온에서 교반한 후 2N 염산을 첨가하여 반응액의 pH를 2로 조정하였다. 반응액을 디클로로메탄(200㎖)으로 2회 추출하여 유기층을 농축시킨 후 실리카겔 칼럼 크로마토그라피로 분리 정제하여 백색의 표제화합물(3.76g, 18mmol, 수율 90%)을 수득하였다.2-cyano-3-isopropylsulfanylpyridine (3.56 g, 20 mmol) was dissolved in tetrahydrofuran (40 mL) and an ether solution (8 mL) of 3M ethylmagnesium bromide was added dropwise at 0 ° C. When the starting material was completely consumed, the mixture was stirred at room temperature for 1 hour, and then the pH of the reaction solution was adjusted to 2 by adding 2N hydrochloric acid. The reaction solution was extracted twice with dichloromethane (200 mL), the organic layer was concentrated and separated and purified by silica gel column chromatography to obtain a white title compound (3.76 g, 18 mmol, 90% yield).
1H NMR (CDCl3, δ): 8.38(d, 1H), 7.75(d, 1H), 7.40∼7.32(m, 1H), 3.49 (quin, 1H), 3.18(q, 2H), 1.38(d, 6H), 1.21(t, 3H) 1 H NMR (CDCl 3 , δ): 8.38 (d, 1H), 7.75 (d, 1H), 7.40-7.32 (m, 1H), 3.49 (quin, 1H), 3.18 (q, 2H), 1.38 (d , 6H), 1.21 (t, 3H)
실시예 1Example 1
1-(3-이소프로필설파닐피리딘-2-일)-2-클로로프로판-1-온의 합성Synthesis of 1- (3-isopropylsulfanylpyridin-2-yl) -2-chloropropan-1-one
1-(3-이소프로필설파닐피리딘-2-일)-프로판-1-온(1.88g, 9mmol)을 톨루엔(20㎖)에 녹인 후 2.2당량의 염화구리(II) (2.66g, 19.8mmol)를 넣고 상온에서 5시간동안 교반하였다. 반응액에 물(25㎖)를 적가한 후 생성된 고체를 셀라이트 통과시켜 여과하였다. 여액을 층분리한 후 수층을 톨루엔(10㎖)으로 2회 추출하였다. 모아진 유기층을 농축시킨 후 실리카겔 칼럼 크로마토그라피로 분리 정제하여 백색의 표제화합물(1.76g, 7.2mmol, 수율 80%)을 수득하였다.Dissolve 1- (3-isopropylsulfanylpyridin-2-yl) -propan-1-one (1.88 g, 9 mmol) in toluene (20 mL), followed by 2.2 equivalents of copper (II) chloride (2.66 g, 19.8 mmol). ) Was added and stirred at room temperature for 5 hours. Water (25 mL) was added dropwise to the reaction solution, and the resulting solid was filtered through celite. The filtrate was separated and the aqueous layer was extracted twice with toluene (10 mL). The combined organic layers were concentrated and separated and purified by silica gel column chromatography to obtain a white title compound (1.76 g, 7.2 mmol, yield 80%).
1H NMR (CDCl3, δ): 8.43(d, 1H), 7.77(d, 1H), 7.43∼7.37(m, 1H), 6.01(q, 1H), 3.51(quin, 1H), 1.73(d, 3H), 1.45∼1.37(m, 6H) 1 H NMR (CDCl 3 , δ): 8.43 (d, 1H), 7.77 (d, 1H), 7.43-7.37 (m, 1H), 6.01 (q, 1H), 3.51 (quin, 1H), 1.73 (d , 3H), 1.45-1.37 (m, 6H)
실시예 2Example 2
1-(3-벤질설파닐피리딘-2-일)-2-클로로프로판-1-온의 합성Synthesis of 1- (3-benzylsulfanylpyridin-2-yl) -2-chloropropan-1-one
1-(3-벤질설파닐피리딘-2-일)-프로판-1-온(2.57g, 10mmol)을 실시예 1에서와 동일한 방법으로 염화구리(II) (2.96g, 22mmol)과 반응시켜 표제화합물(2.62g, 9mmol, 수율 90%)을 수득하였다.1- (3-benzylsulfanylpyridin-2-yl) -propan-1-one (2.57 g, 10 mmol) was reacted with copper (II) chloride (2.96 g, 22 mmol) in the same manner as in Example 1 to give the title Compound (2.62 g, 9 mmol, yield 90%) was obtained.
1H NMR (CDCl3, δ): 8.42(d, 1H), 7.74(d, 1H), 7.48∼7.27(m, 6H), 6.01(q, 1H), 4.17(s, 2H), 1.73(d, 3H) 1 H NMR (CDCl 3 , δ): 8.42 (d, 1H), 7.74 (d, 1H), 7.48-7.27 (m, 6H), 6.01 (q, 1H), 4.17 (s, 2H), 1.73 (d , 3H)
실시예 3Example 3
1-(3-이소프로필설파닐피리딘-2-일)-2-브로모프로판-1-온의 합성Synthesis of 1- (3-isopropylsulfanylpyridin-2-yl) -2-bromopropan-1-one
1-(3-이소프로필설파닐피리딘-2-일)-프로판-1-온(1.88g, 9mmol)을 톨루엔(20㎖)에 녹인 후 2.2당량의 브롬화구리(II) (4.42g, 19.8mmol)를 넣고 상온에서 5시간동안 교반하였다. 반응액에 물(25㎖)를 적가한 후 생성된 고체를 셀라이트 통과시켜 여과하였다. 여액을 층분리한 후 수층을 톨루엔(10㎖)으로 2회 추출하였다. 모아진 유기층을 농축시킨 후 실리카겔 칼럼 크로마토그라피로 분리 정제하여 백색의 표제화합물(2.20g, 7.65mmol, 수율 85%)을 수득하였다.Dissolve 1- (3-isopropylsulfanylpyridin-2-yl) -propan-1-one (1.88 g, 9 mmol) in toluene (20 mL), followed by 2.2 equivalents of copper bromide (II) (4.42 g, 19.8 mmol). ) Was added and stirred at room temperature for 5 hours. Water (25 mL) was added dropwise to the reaction solution, and the resulting solid was filtered through celite. The filtrate was separated and the aqueous layer was extracted twice with toluene (10 mL). The combined organic layers were concentrated and separated and purified by silica gel column chromatography to obtain a white title compound (2.20 g, 7.65 mmol, yield 85%).
1H NMR (CDCl3, δ): 8.43(d, 1H), 7.79(d, 1H), 7.44∼7.37(m, 1H), 6.06 (q, 1H), 3.53(quin, 1H), 1.91(d, 3H), 1.42(dd, 6H) 1 H NMR (CDCl 3 , δ): 8.43 (d, 1H), 7.79 (d, 1H), 7.44-7.37 (m, 1H), 6.06 (q, 1H), 3.53 (quin, 1H), 1.91 (d , 3H), 1.42 (dd, 6H)
실시예 4Example 4
디티오카본산 O-에틸, S-[2-(2-브로모프로피오닐)피리딘-3-일] 에스테르의 합성Synthesis of Dithiocarboxylic Acid O-ethyl, S- [2- (2-bromopropionyl) pyridin-3-yl] Ester
디티오카본산 O-에틸, S-[2-(프로피오닐)피리딘-3-일] 에스테르(2.55g, 10mmol)을 실시예 3에서와 동일한 방법으로 브롬화구리(II) (4.91g, 22mmol)과 반응시켜 표제화합물(3.00g, 9mmol, 수율 90%)을 수득하였다.Dithiocarboxylic acid O-ethyl, S- [2- (propionyl) pyridin-3-yl] ester (2.55 g, 10 mmol) was prepared in the same manner as in Example 3 with copper (II) bromide (4.91 g, 22 mmol). Reaction gave the title compound (3.00 g, 9 mmol, yield 90%).
1H NMR (CDCl3, δ): 8.41(d, 1H), 7.72(d, 1H), 7.40∼7.37(m, 1H), 6.07(q, 1H), 2.92(q, 2H), 1.89(d, 3H), 1.38(t, 3H) 1 H NMR (CDCl 3 , δ): 8.41 (d, 1H), 7.72 (d, 1H), 7.40-7.37 (m, 1H), 6.07 (q, 1H), 2.92 (q, 2H), 1.89 (d , 3H), 1.38 (t, 3H)
실시예 5Example 5
1-(3-벤질설파닐피리딘-2-일)-2-브로모프로판-1-온의 합성Synthesis of 1- (3-benzylsulfanylpyridin-2-yl) -2-bromopropan-1-one
1-(3-벤질설파닐피리딘-2-일)-프로판-1-온(2.57g, 10mmol)을 실시예 3에서와 동일한 방법으로 브롬화구리(II) (4.91g, 22mmol)과 반응시켜 표제화합물(3.03g, 9mmol, 수율 90%)을 수득하였다.Reacting 1- (3-benzylsulfanylpyridin-2-yl) -propan-1-one (2.57 g, 10 mmol) with copper (II) bromide (4.91 g, 22 mmol) in the same manner as in Example 3 Compound (3.03 g, 9 mmol, yield 90%) was obtained.
1H NMR (CDCl3, δ): 8.41(d, 1H), 7.73(d, 1H), 7.44∼7.29(m, 6H), 6.05 (q, 1H), 4.17(s, 2H), 1.90(d, 3H) 1 H NMR (CDCl 3 , δ): 8.41 (d, 1H), 7.73 (d, 1H), 7.44-7.29 (m, 6H), 6.05 (q, 1H), 4.17 (s, 2H), 1.90 (d , 3H)
실시예 6Example 6
1-(3-t-부틸설파닐피리딘-2-일)-2-브로모프로판-1-온의 합성Synthesis of 1- (3-t-butylsulfanylpyridin-2-yl) -2-bromopropan-1-one
1-(3-t-부틸설파닐피리딘-2-일)-프로판-1-온(2.57g, 10mmol)을 실시예 3에서와 동일한 방법으로 브롬화구리(II) (4.91g, 22mmol)과 반응시켜 표제화합물 (2.11g, 7mmol, 수율 70%)을 수득하였다.Reaction of 1- (3-t-butylsulfanylpyridin-2-yl) -propan-1-one (2.57 g, 10 mmol) with copper (II) bromide (4.91 g, 22 mmol) in the same manner as in Example 3 To give the title compound (2.11 g, 7 mmol, yield 70%).
1H NMR (CDCl3, δ): 8.57(d, 1H), 7.90(d, 1H), 7.36∼7.30(m, 1H), 6.07 (q, 1H), 3.10(q, 1H), 1.24(s, 9H), 1.15(t, 3H) 1 H NMR (CDCl 3 , δ): 8.57 (d, 1H), 7.90 (d, 1H), 7.36-7.30 (m, 1H), 6.07 (q, 1H), 3.10 (q, 1H), 1.24 (s , 9H), 1.15 (t, 3H)
실시예 7Example 7
비스((2-(2-브로모프로피오닐)피리딘-3-일)-디설파이드의 합성Synthesis of Bis ((2- (2-bromopropionyl) pyridin-3-yl) -disulfide
비스((2-프로피오닐)피리딘-3-일)-디설파이드(3.32g, 10mmol)을 실시예 3에서와 동일한 방법으로 브롬화구리(II) (9.82g, 44mmol)과 반응시켜 표제화합물 (3.43g, 7mmol, 수율 70%)을 수득하였다.Bis ((2-propionyl) pyridin-3-yl) -disulfide (3.32 g, 10 mmol) was reacted with copper (II) bromide (9.82 g, 44 mmol) in the same manner as in Example 3 to give the title compound (3.43 g , 7 mmol, yield 70%) was obtained.
1H NMR (CDCl3, δ): 8.45(d, 1H), 8.10(d, 1H), 7.42∼7.35(m, 1H), 6.08 (q, 1H), 1.98(d, 3H) 1 H NMR (CDCl 3 , δ): 8.45 (d, 1H), 8.10 (d, 1H), 7.42-7.35 (m, 1H), 6.08 (q, 1H), 1.98 (d, 3H)
실시예 8Example 8
1-(3-벤질설파닐피리딘-2-일)-2-플루오로프로판-1-온의 합성Synthesis of 1- (3-benzylsulfanylpyridin-2-yl) -2-fluoropropane-1-one
1-(3-벤질설파닐피리딘-2-일)-2-클로로프로판-1-온(1.46g, 5mmol)을 폴리에틸렌글리콜300(3㎖)에 녹인 후, 여기에 불화칼륨(0.51g, 8.75mmol)을 투입하였다. 70℃로 5시간동안 가열한 후 냉각시켰다. 톨루엔(5㎖)와 물(5㎖)를 투입한 후 층분리하였다. 유기층을 30% 황산수용액(1㎖)으로 닦아낸 후 산성백토를 통과시켜 여과하였다. 여액을 농축시킨 후 실리카겔 칼럼 크로마토그라피로 분리 정제하여 백색의 표제화합물(1.10g, 4mmol, 수율 80%)을 수득하였다.1- (3-benzylsulfanylpyridin-2-yl) -2-chloropropan-1-one (1.46 g, 5 mmol) was dissolved in polyethylene glycol 300 (3 mL), followed by potassium fluoride (0.51 g, 8.75). mmol) was added. It was heated to 70 ° C. for 5 hours and then cooled. Toluene (5 mL) and water (5 mL) were added, and the layers were separated. The organic layer was washed with 30% aqueous sulfuric acid solution (1 ml) and filtered through acidic clay. The filtrate was concentrated and separated and purified by silica gel column chromatography to obtain a white title compound (1.10g, 4mmol, yield 80%).
1H NMR (CDCl3, δ): 8.38(d, 1H), 7.75(d, 1H), 7.48∼7.29(m, 6H), 6.28 (dq, 1H, J1=51Hz), 4.16(s, 2H), 1.67(dd, 3H, J1=27Hz) 1 H NMR (CDCl 3 , δ): 8.38 (d, 1H), 7.75 (d, 1H), 7.48-7.29 (m, 6H), 6.28 (dq, 1H, J 1 = 51 Hz), 4.16 (s, 2H) , 1.67 (dd, 3H, J1 = 27 Hz)
실시예 9Example 9
1-(3-이소프로필설파닐피리딘-2-일)-2-플루오로프로판-1-온의 합성Synthesis of 1- (3-isopropylsulfanylpyridin-2-yl) -2-fluoropropane-1-one
1-(3-이소프로필설파닐피리딘-2-일)-2-브로모프로판-1-온(1.44g, 5mmol)을 폴리에틸렌글리콜300(3㎖)에 녹인 후 실시예 8에서와 동일한 방법으로 불화칼륨 (0.51g, 8.75mmol)과 반응시켜 표제화합물(0.91g, 4mmol, 수율 80%)을 수득하였다.1- (3-isopropylsulfanylpyridin-2-yl) -2-bromopropane-1-one (1.44 g, 5 mmol) was dissolved in polyethylene glycol 300 (3 mL), and the same procedure as in Example 8 was performed. Reaction with potassium fluoride (0.51 g, 8.75 mmol) gave the title compound (0.91 g, 4 mmol, yield 80%).
1H NMR (CDCl3, δ): 8.37(d, 1H), 7.77(d, 1H), 7.42∼7.37(m, 1H), 6.23 (dq, 1H, J1=62Hz), 3.52(quin, 1H), 1.70(d, 3H), 1.50(dd, 6H, J1=65Hz) 1 H NMR (CDCl 3 , δ): 8.37 (d, 1H), 7.77 (d, 1H), 7.42-7.37 (m, 1H), 6.23 (dq, 1H, J 1 = 62 Hz), 3.52 (quin, 1H) , 1.70 (d, 3H), 1.50 (dd, 6H, J1 = 65 Hz)
실시예 10Example 10
디티오카본산 O-에틸, S-[2-(2-플루오로프로피오닐)피리딘-3-일] 에스테르의 합성Synthesis of Dithiocarboxylic Acid O-ethyl, S- [2- (2-fluoropropionyl) pyridin-3-yl] Ester
디티오카본산 O-에틸, S-[2-(2-브로모프로피오닐)피리딘-3-일] 에스테르 (1.67g, 5mmol)을 폴리에틸렌글리콜300(3㎖)에 녹인 후 실시예 8에서와 동일한 방법으로 불화칼륨(0.51g, 8.75mmol)과 반응시켜 표제화합물(0.98g, 3.6mmol, 수율 72%)을 수득하였다.Dithiocarboxylic acid O-ethyl, S- [2- (2-bromopropionyl) pyridin-3-yl] ester (1.67 g, 5 mmol) was dissolved in polyethylene glycol 300 (3 mL) and then the same as in Example 8 Reaction with potassium fluoride (0.51 g, 8.75 mmol) gave the title compound (0.98 g, 3.6 mmol, yield 72%).
1H NMR (CDCl3, δ): 8.37(d, 1H), 7.73(d, 1H), 7.43∼7.37(m, 1H), 6.29 (dq, 1H, J1=65Hz), 2.94(q, 2H), 1.70(dd, 3H, J1=49Hz), 1.42 (t, 3H) 1 H NMR (CDCl 3 , δ): 8.37 (d, 1H), 7.73 (d, 1H), 7.43-7.37 (m, 1H), 6.29 (dq, 1H, J 1 = 65 Hz), 2.94 (q, 2H) , 1.70 (dd, 3H, J1 = 49 Hz), 1.42 (t, 3H)
실시예 11Example 11
N-t-부틸-[2-(2-플루오르프로피오닐)-피리딘-3-일]설폰아미드의 합성Synthesis of N-t-butyl- [2- (2-fluoropropionyl) -pyridin-3-yl] sulfonamide
1-(3-벤질설파닐피리딘-2-일)-2-플루오로프로판-1-온 (2.75g, 10mmol)을 디클로로메탄(10㎖)와 초산(10㎖)에 묽힌 후 0℃에서 염소(기체)를 30분 동안 버블링시켰다. 반응액이 투명한 노랑색으로 변하면 염소 투입을 중지하고 반응액에 질소를 1시간 버블링하여 과량의 염소를 제거하였다. 반응액을 정치시켜 층분리한 후 유기층을 0℃로 냉각시켰다. 냉각된 유기층에 t-부틸아민(11mmol)을 적가하였다. 반응액에 물(10㎖)를 넣어 추출한 후 유기층을 농축시키고 실리카겔 칼럼 크로마토그라피로 분리 정제하여 백색의 표제화합물(2.33g, 8.1mmol, 수율 81%)을 수득하였다.Dilute 1- (3-benzylsulfanylpyridin-2-yl) -2-fluoropropane-1-one (2.75 g, 10 mmol) in dichloromethane (10 mL) and acetic acid (10 mL), and then chlorine at 0 ° C. (Gas) was bubbled for 30 minutes. When the reaction solution turned transparent yellow, the chlorine was stopped and nitrogen was bubbled into the reaction solution for 1 hour to remove excess chlorine. The reaction solution was left to stand and the layers were separated, and then the organic layer was cooled to 0 ° C. T-butylamine (11 mmol) was added dropwise to the cooled organic layer. Water (10 mL) was added to the reaction mixture, followed by concentration. The organic layer was concentrated and separated and purified by silica gel column chromatography to obtain a white title compound (2.33 g, 8.1 mmol, 81% yield).
이상 설명한 바와 같이, 본 발명에 따른 신규한 화학식 (1)의 화합물을 사용하면 우수한 제초활성을 갖는 화학식 (2)의 화합물을 제조하는 핵심 중간체로서 작용하는 화학식 (5)의 화합물을 매우 효율적으로 제조할 수 있다.As described above, the use of the novel compounds of formula (1) according to the present invention makes it very efficient to prepare compounds of formula (5) which serve as key intermediates for the preparation of compounds of formula (2) having excellent herbicidal activity. can do.
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020024057A KR100641908B1 (en) | 2002-05-02 | 2002-05-02 | Pyridine derivatives, process for the preparation thereof, and use as an intermediate of herbicides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020024057A KR100641908B1 (en) | 2002-05-02 | 2002-05-02 | Pyridine derivatives, process for the preparation thereof, and use as an intermediate of herbicides |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030085788A true KR20030085788A (en) | 2003-11-07 |
KR100641908B1 KR100641908B1 (en) | 2006-11-02 |
Family
ID=32381171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020020024057A KR100641908B1 (en) | 2002-05-02 | 2002-05-02 | Pyridine derivatives, process for the preparation thereof, and use as an intermediate of herbicides |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100641908B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101146333B1 (en) * | 2003-12-03 | 2012-05-21 | 주식회사 엘지생명과학 | Novel Pyridine-based Compounds and Processes for Preparation of the Same |
WO2014010990A1 (en) * | 2012-07-13 | 2014-01-16 | Lg Life Sciences Ltd. | Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same |
WO2015053576A1 (en) * | 2013-10-11 | 2015-04-16 | Lg Life Sciences Ltd. | Method for preparation of 3-alkylthio-2-bromopyridine |
CN104829524A (en) * | 2014-02-11 | 2015-08-12 | Fmc公司 | Synthetic method of intermediate of herbicide flucetosulfuron |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL96706A (en) * | 1989-12-29 | 1995-06-29 | Basf Ag | 3-substituted pyridines their manufacture and their use as fungicides |
IL109104A (en) * | 1993-03-26 | 1998-08-16 | Shell Int Research | 2,6-substituted pyridine derivatives their preparation and herbicidal compositions containing them |
US5595958A (en) * | 1994-05-02 | 1997-01-21 | Zeneca Limited | 3-substituted pyridine compounds and derivatives thereof |
-
2002
- 2002-05-02 KR KR1020020024057A patent/KR100641908B1/en active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101146333B1 (en) * | 2003-12-03 | 2012-05-21 | 주식회사 엘지생명과학 | Novel Pyridine-based Compounds and Processes for Preparation of the Same |
WO2014010990A1 (en) * | 2012-07-13 | 2014-01-16 | Lg Life Sciences Ltd. | Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same |
KR101493488B1 (en) * | 2012-07-13 | 2015-02-16 | 주식회사 엘지생명과학 | Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same |
CN104487419A (en) * | 2012-07-13 | 2015-04-01 | 株式会社Lg生命科学 | Novel pyridine derivatives and method for preparation of intermediate compound for producing sulfonylurea herbicides using the same |
WO2015053576A1 (en) * | 2013-10-11 | 2015-04-16 | Lg Life Sciences Ltd. | Method for preparation of 3-alkylthio-2-bromopyridine |
CN105636938A (en) * | 2013-10-11 | 2016-06-01 | 株式会社Lg生命科学 | Method for preparation of 3-alkylthio-2-bromopyridine |
CN104829524A (en) * | 2014-02-11 | 2015-08-12 | Fmc公司 | Synthetic method of intermediate of herbicide flucetosulfuron |
JP2017506634A (en) * | 2014-02-11 | 2017-03-09 | エフ エム シー コーポレーションFmc Corporation | Process for the synthesis of flucetosulfuron herbicide intermediates |
Also Published As
Publication number | Publication date |
---|---|
KR100641908B1 (en) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI695824B (en) | Process for preparing 3-chloro-2-vinylphenylsulfonates | |
DK149623B (en) | PROCEDURE FOR THE PREPARATION OF ALFA-HYDROXYCARBOXYLIC ACIDAMIDS | |
RU2236403C2 (en) | Method for preparing derivatives of 5-amino-1-aryl-3-cyanopyrazole and intermediate compounds for their synthesis | |
KR100641908B1 (en) | Pyridine derivatives, process for the preparation thereof, and use as an intermediate of herbicides | |
EP0357404B1 (en) | Process for the preparation of cyclopentane derivatives | |
JP3880883B2 (en) | Pyridine derivatives, methods for producing the same, and uses as herbicide intermediates | |
JP4026233B2 (en) | Method for producing 4,5-dichloro-6- (α-fluoroalkyl) pyrimidine | |
JPS63145286A (en) | Bicyclic imidazole derivative | |
US20040092750A1 (en) | 2-methylindole-4-acetic acid, process for producing the same, and process for producing intermediate therefor | |
JP3006237B2 (en) | Preparation of aminopyrazole derivatives | |
JP4899385B2 (en) | Method for producing 3-aminomethyloxetane compound | |
CN111527072A (en) | Method for producing herbicidal pyridazinone compound | |
CA2456531C (en) | Process for the preparation of 4-(imidazole-1-yl)benzenesulfonamide derivatives | |
KR100424341B1 (en) | A process for preparing 1-Methyl- indazole-3-carboxylic acid | |
JP3799580B2 (en) | Process for producing N-substituted-N-sulfonylamides | |
JP3646225B2 (en) | Aromatic ester derivatives, intermediates thereof, and methods for producing them | |
WO2024024766A1 (en) | Alkyl halide, alkylating agent using same, and method for producing derivative of nucleotide | |
US4837350A (en) | Process for the preparation of benzoin sulfonates | |
KR100212636B1 (en) | New process for preparing herbicidal pyrimidyloxybenzoic acid oxime ester derivatives | |
KR810000815B1 (en) | Preparing process for 4-benzoyl pyrazol derivatives and its aluminum salts | |
JPH09124610A (en) | 1,2-diformylhexahydropyridazine, its production and production of hexahydropyridazine | |
JPH06228103A (en) | New octahydroacridine derivative and its production | |
JP4055246B2 (en) | 5-chloro-6- (α-fluoroalkyl) -4-pyrimidone and process for producing the same | |
JPH07247263A (en) | Production of methylthiobenzene compound | |
KR100467979B1 (en) | Fluorine-substituted heterocyclic compounds as intermediate for synthesis of agrochemical and medicinal antagonist and method for preparing thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121011 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130911 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140915 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150924 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160912 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170919 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20181016 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20191016 Year of fee payment: 14 |